BioMarin Pharmaceutical Inc. (BM8.DE)
EUR 63.52
(0.92%)
EUR 63.52
(0.92%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.89 USD | 17.11% |
| 2022 | 0.76 USD | 317.14% |
| 2021 | -0.35 USD | -107.42% |
| 2020 | 4.72 USD | 3730.77% |
| 2019 | -0.13 USD | 70.45% |
| 2018 | -0.44 USD | 34.33% |
| 2017 | -0.67 USD | 82.37% |
| 2016 | -3.80 USD | -255.14% |
| 2015 | -1.07 USD | -16.3% |
| 2014 | -0.92 USD | 28.13% |
| 2013 | -1.28 USD | -34.74% |
| 2012 | -0.95 USD | -97.92% |
| 2011 | -0.48 USD | -124.0% |
| 2010 | 2.00 USD | 40916.33% |
| 2009 | -0.00 USD | -101.58% |
| 2008 | 0.31 USD | 293.75% |
| 2007 | -0.16 USD | 52.94% |
| 2006 | -0.34 USD | 68.52% |
| 2005 | -1.08 USD | 62.89% |
| 2004 | -2.91 USD | -138.52% |
| 2003 | -1.22 USD | 15.86% |
| 2002 | -1.45 USD | 12.12% |
| 2001 | -1.65 USD | -58.65% |
| 2000 | -1.04 USD | -10.64% |
| 1999 | -0.94 USD | -70.91% |
| 1998 | -0.55 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.47 USD | 327.27% |
| 2023 Q1 | 0.27 USD | 20869.23% |
| 2023 FY | - USD | 17.11% |
| 2023 Q3 | 0.21 USD | -30.0% |
| 2023 Q4 | 0.11 USD | -47.62% |
| 2023 Q2 | 0.30 USD | 11.11% |
| 2022 Q4 | -0.00 USD | 96.37% |
| 2022 Q3 | -0.04 USD | -123.87% |
| 2022 Q1 | 0.62 USD | 293.75% |
| 2022 Q2 | 0.15 USD | -75.81% |
| 2022 FY | - USD | 317.14% |
| 2021 Q3 | -0.20 USD | -382.49% |
| 2021 Q4 | -0.32 USD | -60.0% |
| 2021 FY | - USD | -107.42% |
| 2021 Q1 | 0.10 USD | -20.33% |
| 2021 Q2 | 0.07 USD | -25.94% |
| 2020 FY | - USD | 3730.77% |
| 2020 Q3 | 4.33 USD | 2806.25% |
| 2020 Q1 | 0.45 USD | 437.63% |
| 2020 Q2 | -0.16 USD | -135.56% |
| 2020 Q4 | 0.12 USD | -97.23% |
| 2019 Q2 | -0.21 USD | 34.38% |
| 2019 FY | - USD | 70.45% |
| 2019 Q1 | -0.32 USD | -1460.98% |
| 2019 Q4 | 0.08 USD | -73.0% |
| 2019 Q3 | 0.31 USD | 247.62% |
| 2018 Q2 | -0.09 USD | 62.04% |
| 2018 FY | - USD | 34.33% |
| 2018 Q1 | -0.25 USD | 13.79% |
| 2018 Q3 | -0.07 USD | 25.08% |
| 2018 Q4 | -0.02 USD | 71.17% |
| 2017 Q2 | -0.21 USD | -122.69% |
| 2017 Q3 | -0.07 USD | 65.95% |
| 2017 FY | - USD | 82.37% |
| 2017 Q1 | -0.09 USD | 82.21% |
| 2017 Q4 | -0.29 USD | -305.59% |
| 2016 Q4 | -0.53 USD | -103.85% |
| 2016 Q2 | -2.61 USD | -392.45% |
| 2016 Q1 | -0.53 USD | -223.26% |
| 2016 FY | - USD | -255.14% |
| 2016 Q3 | -0.26 USD | 90.04% |
| 2015 FY | - USD | -16.3% |
| 2015 Q1 | -0.43 USD | 8.51% |
| 2015 Q4 | 0.43 USD | 175.44% |
| 2015 Q3 | -0.57 USD | -11.76% |
| 2015 Q2 | -0.51 USD | -18.6% |
| 2014 Q1 | -0.26 USD | 0.0% |
| 2014 Q4 | -0.47 USD | -1028.85% |
| 2014 FY | - USD | 28.13% |
| 2014 Q3 | 0.05 USD | 122.0% |
| 2014 Q2 | -0.23 USD | 11.54% |
| 2013 Q2 | -0.15 USD | 51.61% |
| 2013 Q1 | -0.31 USD | 27.91% |
| 2013 Q3 | -0.38 USD | -153.33% |
| 2013 Q4 | - USD | 100.0% |
| 2013 FY | - USD | -34.74% |
| 2012 FY | - USD | -97.92% |
| 2012 Q4 | -0.43 USD | -890.78% |
| 2012 Q1 | -0.21 USD | 0.0% |
| 2012 Q2 | -0.27 USD | -28.57% |
| 2012 Q3 | -0.04 USD | 83.93% |
| 2011 Q2 | -0.05 USD | -15.7% |
| 2011 Q4 | - USD | 100.0% |
| 2011 FY | - USD | -124.0% |
| 2011 Q3 | -0.16 USD | -250.11% |
| 2011 Q1 | -0.04 USD | 0.0% |
| 2010 Q1 | 0.01 USD | 0.0% |
| 2010 Q2 | -0.00 USD | -141.23% |
| 2010 Q3 | 2.13 USD | 45419.15% |
| 2010 Q4 | - USD | -100.0% |
| 2010 FY | - USD | 40916.33% |
| 2009 Q4 | - USD | -100.0% |
| 2009 Q3 | 0.07 USD | 405.34% |
| 2009 FY | - USD | -101.58% |
| 2009 Q1 | -0.13 USD | 0.0% |
| 2009 Q2 | 0.01 USD | 110.08% |
| 2008 Q2 | 0.04 USD | 122.54% |
| 2008 Q4 | - USD | -100.0% |
| 2008 Q3 | 0.01 USD | -78.44% |
| 2008 Q1 | 0.02 USD | 0.0% |
| 2008 FY | - USD | 293.75% |
| 2007 Q1 | -0.10 USD | 0.0% |
| 2007 Q2 | -0.04 USD | 59.0% |
| 2007 Q4 | - USD | 100.0% |
| 2007 Q3 | -0.05 USD | -34.49% |
| 2007 FY | - USD | 52.94% |
| 2006 Q2 | -0.02 USD | 88.08% |
| 2006 Q3 | -0.08 USD | -426.45% |
| 2006 FY | - USD | 68.52% |
| 2006 Q4 | - USD | 100.0% |
| 2006 Q1 | -0.13 USD | 0.0% |
| 2005 Q2 | -0.33 USD | 5.71% |
| 2005 Q1 | -0.35 USD | 0.0% |
| 2005 Q3 | -0.21 USD | 36.36% |
| 2005 Q4 | - USD | 100.0% |
| 2005 FY | - USD | 62.89% |
| 2004 Q3 | -0.46 USD | 46.51% |
| 2004 Q2 | -0.86 USD | -177.42% |
| 2004 Q1 | -0.31 USD | 0.0% |
| 2004 FY | - USD | -138.52% |
| 2004 Q4 | - USD | 100.0% |
| 2003 FY | - USD | 15.86% |
| 2003 Q1 | -0.35 USD | 0.0% |
| 2003 Q2 | -0.14 USD | 60.0% |
| 2003 Q3 | -0.33 USD | -135.71% |
| 2003 Q4 | - USD | 100.0% |
| 2002 Q3 | -0.32 USD | -18.52% |
| 2002 Q4 | - USD | 100.0% |
| 2002 FY | - USD | 12.12% |
| 2002 Q1 | -0.51 USD | 0.0% |
| 2002 Q2 | -0.27 USD | 47.06% |
| 2001 Q3 | -0.26 USD | 13.33% |
| 2001 Q1 | -0.26 USD | 0.0% |
| 2001 Q4 | - USD | 100.0% |
| 2001 Q2 | -0.30 USD | -15.38% |
| 2001 FY | - USD | -58.65% |
| 2000 Q4 | - USD | 100.0% |
| 2000 FY | - USD | -10.64% |
| 2000 Q3 | -0.23 USD | -15.0% |
| 2000 Q1 | -0.34 USD | 0.0% |
| 2000 Q2 | -0.20 USD | 41.18% |
| 1999 Q2 | -0.26 USD | 65.33% |
| 1999 Q3 | -0.24 USD | 7.69% |
| 1999 Q4 | - USD | 100.0% |
| 1999 FY | - USD | -70.91% |
| 1999 Q1 | -0.75 USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| BioNTech SE | 3.87 EUR | 77.003% |
| CureVac N.V. | -1.18 EUR | 175.424% |
| Biotest Aktiengesellschaft | 3.21 EUR | 72.274% |
| Biotest Aktiengesellschaft | 3.21 EUR | 72.274% |
| BRAIN Biotech AG | -0.38 EUR | 334.211% |
| Formycon AG | 4.76 EUR | 81.303% |
| Heidelberg Pharma AG | -0.44 EUR | 302.273% |
| Medigene AG | -0.66 EUR | 234.848% |